30 http://www.imeronline.com/podcast/ en-us Institute for Medical Education and Research Institute for Medical Education and Research Institute for Medical Education and Research podcast@imeronline.com podcast@imeronline.com http://www.imeronline.com/podcast/itunes300x300.jpg The past decade has witnessed important advancements in the systemic treatment of colorectal cancer that have improved the survival of patients with metastatic disease and expanded treatment options in the adjuvant setting. clean IMER Medical Education Oncology Nursing Episode 1 Institute for Medical Education and Research 00:03:47 http://www.imeronline.com/podcast/media/204_podcast_ep_1.mp4 Fri, 06 Jul 2007 10:42:57 -0400 Fri, 06 Jul 2007 10:42:57 -0400 The emergence of multitargeted agents in oncology broadens the scope of targeted therapies for cancer patients. As these agents move into the arena of approved therapies, oncology nurses must understand their mechanisms of action, administration guidelines, potential toxicities, and how to provide adequate education to patients receiving them. In this educational program, recent clinical data on the incorporation of multitargeted agents into the treatment of two therapeutically challenging tumor types, gastrointestinal stromal tumor and renal cell carcinoma, will be presented along with information on the nursing management of patients receiving these novel agents. IMER, cancer, targeted therapies, oncology, toxicities, tumor Episode 2 Institute for Medical Education and Research 00:22:48 http://www.imeronline.com/podcast/media/204_podcast_ep_2.mp4 Fri, 06 Jul 2007 10:44:11 -0400 Fri, 06 Jul 2007 10:44:11 -0400 The emergence of multitargeted agents in oncology broadens the scope of targeted therapies for cancer patients. As these agents move into the arena of approved therapies, oncology nurses must understand their mechanisms of action, administration guidelines, potential toxicities, and how to provide adequate education to patients receiving them. In this educational program, recent clinical data on the incorporation of multitargeted agents into the treatment of two therapeutically challenging tumor types, gastrointestinal stromal tumor and renal cell carcinoma, will be presented along with information on the nursing management of patients receiving these novel agents. IMER, cancer, targeted therapies, oncology, toxicities, tumor Episode 3 Institute for Medical Education and Research 00:24:15 http://www.imeronline.com/podcast/media/204_podcast_ep_3.mp4 Fri, 06 Jul 2007 10:45:13 -0400 Fri, 06 Jul 2007 10:45:13 -0400 The emergence of multitargeted agents in oncology broadens the scope of targeted therapies for cancer patients. As these agents move into the arena of approved therapies, oncology nurses must understand their mechanisms of action, administration guidelines, potential toxicities, and how to provide adequate education to patients receiving them. In this educational program, recent clinical data on the incorporation of multitargeted agents into the treatment of two therapeutically challenging tumor types, gastrointestinal stromal tumor and renal cell carcinoma, will be presented along with information on the nursing management of patients receiving these novel agents. IMER, cancer, targeted therapies, oncology, toxicities, tumor Introduction Institute for Medical Education and Research 00:01:07 http://www.imeronline.com/podcast/media/204_intro.mp4 Fri, 06 Jul 2007 14:28:31 -0400 Fri, 06 Jul 2007 14:28:31 -0400 The emergence of multitargeted agents in oncology broadens the scope of targeted therapies for cancer patients. As these agents move into the arena of approved therapies, oncology nurses must understand their mechanisms of action, administration guidelines, potential toxicities, and how to provide adequate education to patients receiving them. In this educational program, recent clinical data on the incorporation of multitargeted agents into the treatment of two therapeutically challenging tumor types, gastrointestinal stromal tumor and renal cell carcinoma, will be presented along with information on the nursing management of patients receiving these novel agents. IMER, cancer, targeted therapies, oncology, toxicities, tumor